Many patients believe these medications are equivalent to FDA-approved products because they produce similar weight loss or glycemic improvements
GLP-1 (glucagon-like peptide-1) medications are a class of FDA-approved treatments originally developed for type 2 diabetes that have revolutionized medical weight loss
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
And unfortunately, right now NovaMane can only make 100 batches per month
The most clinically relevant interactions for women over 50 involve insulin sensitizers, GLP-1 medications like semaglutide or tirzepatide already in use, certain blood thinners, and corticosteroids
Furthermore, in July 2018, Sanofi invested about USD 74.1 million in China for establishing an R&D hub to enhance its global reach